|
Volumn 28, Issue 13, 2007, Pages 2235-2240
|
Probing the stability of serum protein-ruthenium(III) drug adducts in the presence of extracellular reductants using CE
|
Author keywords
ACE; CE; Protein metallodrug adducts; Ruthenium complexes; Stability studies
|
Indexed keywords
ASCORBIC ACID;
BODY FLUIDS;
ELECTROPHORESIS;
INDUCTIVELY COUPLED PLASMA;
PHYSIOLOGICAL MODELS;
PHYSIOLOGY;
PLASMA STABILITY;
RATE CONSTANTS;
RUTHENIUM COMPOUNDS;
ACE;
ANTI-CANCER AGENTS;
CE;
EXTRACELLULAR;
KINETIC ASSAY;
PROTEIN-METALLODRUG ADDUCT;
REDUCTANTS;
RUTHENIUM COMPLEXES;
SERUM PROTEINS;
STABILITY STUDY;
PROTEINS;
ALBUMIN;
ASCORBIC ACID;
GLUTATHIONE;
INDAZOLIUM TETRACHLOROBIS(INDAZOLE)RUTHENATE;
PLASMA PROTEIN;
RUTHENIUM COMPLEX;
TETRACHLOROBIS(1H INDAZOLE)RUTHENATE;
TRANSFERRIN;
UNCLASSIFIED DRUG;
ARTICLE;
BIOTRANSFORMATION;
CAPILLARY ELECTROPHORESIS;
CELL LEVEL;
DRUG PROTEIN BINDING;
DRUG STABILITY;
DRUG STRUCTURE;
IN VITRO STUDY;
MASS SPECTROMETRY;
OXIDATION REDUCTION REACTION;
|
EID: 34447517227
PISSN: 01730835
EISSN: 15222683
Source Type: Journal
DOI: 10.1002/elps.200600707 Document Type: Article |
Times cited : (47)
|
References (21)
|